These findings highlight the potential of self-complementary AAVs to reduce dose requirements, minimize toxicity, and broaden ...
So, what are retrons? They’re bacterial immune systems that save the bacterial herd by culling individual bacteria infected ...
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.
In a phase 1 trial, a gene-editing therapy that targets ANGPTL3 was associated with few serious adverse events and at higher ...
Researchers report early but encouraging results on an experimental gene-editing treatment for high cholesterol.
A single infusion of CRISPR Therapeutics' experimental gene therapy was safe and reduced levels of harmful LDL cholesterol ...
FIRST TO BOSTON CHILDREN’S BY FINISHING HER FIRST BOSTON MARATHON ON THEIR TEAM AND NOW TO DANA-FARBER. RAISING MONEY FOR ...
Laura J. Zitella, MS, RN, ACNP-BC, AOCN, explains that later cytopenias should be monitored in patients undergoing CAR T-cell ...
Stem cell transplant options have expanded, utilizing matched siblings, unrelated donors, and umbilical cord blood, enhancing access for hematologic cancer patients. October brought developments in ...
Only a few dozen patients with lupus have been treated with CAR-T-cell therapy — but in a small German study, all five ...
Researchers from Rutgers Cancer Institute, New Jersey’s only National Cancer Institute (NCI) - designated Comprehensive ...
About 1 million people in the U.S. live with multiple sclerosis, a chronic autoimmune disease that inflames the nervous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results